Contraception
Contraception
At Exeltis, we offer innovative contraceptive option in the UK, designed to give you a reliable choice that meets the individual needs of your patients. Explore how this option can suit a wide range of patient profiles.
Adverse event reporting can be found at the bottom of the page
Slynd®
Educational
Content
Our Contraceptive Option: Designed for Your Patients
Slynd® (Drospirenone 4mg)
The first oestrogen-free drospirenone POP in the UK.1,2 Slynd® is a progestogen-only pill (POP) indicated for contraception1
Discover other specialized areas in women’s health
Menopause
Support your patients from perimenopause through postmenopause with products, tools, and guidance tailored to every stage of the journey.
Pregnancy
Access trusted tools and guidance on managing nausea and vomiting in pregnancy, helping you support women with compassion and confidence.
1. Slynd® Summary of Product Characteristics. 2. FSRH Clinical Guidelines progestogen-only pills. 07/2023at
Reporting Side Effects
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App store. Adverse events should also be reported to Exeltis UK Limited by email to pharmacovigilance.uk@exeltis.com
